RNA-seq-based expression signature enhances clinical detection of retinoblastoma transcriptional corepressor 1 (RB1) loss in whole-exome sequencing
European Journal of Cancer · 2026-11 · 248 · 117678
DOI: 10.1016/j.ejca.2026.117678 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Makeeva und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Makeeva, A., Khegai, G., Stupichev, D., Korbut, A., Butusova, A., Yudina, A., Mouabbi, J., Haddad, E. N., Scofield, E., Chawla, S., & Bagaev, A. (2026). RNA-seq-based expression signature enhances clinical detection of retinoblastoma transcriptional corepressor 1 (RB1) loss in whole-exome sequencing. European Journal of Cancer, 248, 117678. https://doi.org/10.1016/j.ejca.2026.117678
Vancouver
Makeeva A, Khegai G, Stupichev D, Korbut A, Butusova A, Yudina A, et al. RNA-seq-based expression signature enhances clinical detection of retinoblastoma transcriptional corepressor 1 (RB1) loss in whole-exome sequencing. European Journal of Cancer. 2026;248:117678. doi:10.1016/j.ejca.2026.117678
BibTeX
@article{Makeeva2026,
author = {Makeeva, A. and Khegai, G. and Stupichev, D. and Korbut, A. and Butusova, A. and Yudina, A. and Mouabbi, J. and Haddad, E. Nassif and Scofield, E. and Chawla, S. and Bagaev, A.},
title = {RNA-seq-based expression signature enhances clinical detection of retinoblastoma transcriptional corepressor 1 (RB1) loss in whole-exome sequencing},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117678},
doi = {10.1016/j.ejca.2026.117678}
}
EUVIMED